POSTER SESSION I Monday, March 24, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C GYNECOLOGIC PATHOLOGY 113 p27 Expression in the Development and Behavior of Epithelial Ovarian Tumors (815) AJ Ali, CE Sheehan, JJ Xiong, JS Ross, RA Ambros Albany Medical College, Albany, NY 114 Assessment of a Novel Grading System for Endometrial Carcinoma (820) A Alkushi, P Lim, A Coldman, D Huntsman, D Miller, B Gilks Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada 115 Comparison of E-Cadherin Expression in Eutopic Endometrium, Adenomyosis, Endometriosis, Atypical Endometriosis and Ovarian Carcinoma Arising in Endometriosis (827) S Bandyopadhyay, R Ali-Fehmi, AR Munkarah, WD Lawrence, E Silva The Karmanos Cancer Institute and Harper University Hospital, Wayne State University, Detroit, MI; Brown Medical School, Providence, RI; M.D. Anderson, Houston, TX 116 Interobserver and Intraobserver Variability in the Assessment of Cervical Intraepithelial Lesions in Pap Smears and Biopsies (831) I Boiko, A Malpica, R Wong, EN Atkinson, T Alexeenko, M Follen, L Lemos The University of Texas Medical School, Houston, TX; The University of Texas M.D.Anderson Cancer Center, Houston, TX; The University of Mississippi Medical Center, Jackson, MS 117 Expression of PDGF-R in Epithelial Ovarian Tumors (844) SC Chen, P Sabbatini, DS Marshall, M Leitao, RA Soslow Memorial Sloan-Kettering Cancer Center, New York, NY 118 Expression of Cancer-Testis (CT) Antigens in Endometrial Carcinomas Using a Tissue Micro-Array (847) DA Chitale, A Jungbluth, DS Marshall, MM Leitao, CV Hedvat, D Kolb, K Iversen, RA Soslow Memorial Sloan-Kettering Cancer Center, New York, NY 119 p53, b-Catenin and Cyclin D1 Are Superior to p53 Alone in Distinguishing Problematic Uterine Serous Carcinomas from Endometrioid Carcinomas (853) F Darvishian, R Bhargava, DS Marshall, I Linkov, M Asher, RA Soslow Memorial Sloan-Kettering Cancer Center, New York, NY 120 Can the Implants of Serous Borderline Tumors of the Ovary Be Distinguished from Mesothelial Proliferations by Use of Immunohistochemistry? (867) A Gupta, AK Bhan, DA Bell Massachusetts General Hospital, Boston, MA 121 Emi-1 Is Upregulated in Clear Cell Carcinomas of the Ovary: A Preliminary Comparative Analysis of Protein Expression Using Ovarian Tissue Arrays (869) I Gutgemann, J Hsiu, N Lehman, K Montgomery, M Masek, P Jackson, T Longacre Stanford University, Stanford, CA 122 Cyclooxygenase-2 and MIB-1 in Normal and Pathologic Ovaries: Correlations with Ovulation, Follicular Cysts and Cancer (877) M Imkie, OW Tawfik, MK Davis, J Kirchoff, C Fabian, V Montgomery-Rice, P Terranova, M Danley Kansas Univ Med Ctr, Kansas City, KS 123 Amplification of a Novel BRCA2-Inactivating Gene, EMSY, in High Grade Ovarian Carcinomas (879) J Irving, L Brown, T Magliocco, T Longacre, B Gilks, C Caldas, D Huntsman Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada; University of Calgary, Calgary, AB, Canada; Stanford University, Stanford, CA; University of Cambridge, Cambridge, United Kingdom 124 Expression of Cox-2, CD34, bcl-2 and P-53 and Survival in Patients with Primary Peritoneal Serous Carcinoma (PPC) in Comparison to Primary Ovarian Serous Carcinoma (OSC) (887) I Khalifeh, R Ali-Fehmi, S Bandynopadhyay, AR Munkarah, R Morris, WD Lawrence The Karmanos Cancer Institute and Harper University Hospital, Wayne State University, Detroit, MI; Women & Infants Hospital, Brown Medical School, Providence, RI 125 Expression of Steroid Hormone Receptors and Prognostic Significance in Ovarian Cancer Using Tissue Microarray (893) P Lee, D Rosen, KQ Cai, DM Gershenson, EG Silva, JS Liu M.D. Anderson Cancer Center, Houston, TX 126 Metaplastic Process of Ovarian Endometriosis - A Morphologic Study (896) N Li, BZ Senturk, W Zheng Yale University, New Haven, CT 127 Endometrial Gladular Dysplasia, a Preneoplastic Lesion of Endometrial Intraepithelial Carcinoma (EIC): A Morphological Study (898) SX Liang, V Parkash, W Zheng Yale University School of Medicine, New Haven, CT 128 Atypical Immature Squamous Metaplasia of Uterine Cervix: A Study of Its Immunoprofile Using p16INK4, Ki-67, p63, and p53 (902) F Liu, MR Quddus, CJ Sung, C Zhang, MM Steinhoff, WD Lawrence Women & Infants Hospital, Brown Medical School, Providence, RI 129 Cervical Eosinophilic Dysplasia - A Newly Recognized Variant of High-Grade Cervical Intraepithelial Neoplasia (CIN) (909) L Ma, J Fisk, V Parkash, W Zheng Yale New Haven Hospital, New Haven, CT 130 Value of Multilevel Sectioning for Improved Detection of Micrometastases in Sentinel Lymph Nodes in Invasive Squamous Cell Carcinoma of Vulva (918) A Nasir, R Raghuwanshi, M Ghayouri, A Hakam Univ. of South Florida & H.Lee Moffitt Cancer Center & Research Institute, Tampa, FL 131 Cox-2 and Ki-67 Protein Expression and Angiogenesis in Ovarian Granulosa Cell Tumors (937) E Pryor, R Ali-Fehmi, AR Munkarah, WD Lawrence Harper University Hospital; The Karmanos Cancer Institute; Wayne State University School of Medicine, Detroit, MI; Women and Infants Hospital and Brown Medical School, Providence, RI 132 Differentiating Cervical High-Grade Intraepithelial Lesion (HSIL) from Atrophy in Postmenopausal Women Using Ki-67, Cyclin E and p16 Immunohistochemical (IHC) Stains (939) X Qiao, TA Bhuiya Long Island Jewish Medical Center, New Hyde Park, NY 133 Histologic Correlates of Placental Infection Associated with Severe Morbidity in the Newborn (955) A Satoskar, N Ramirez, GJ Nuovo Ohio State University, Columbus, OH 134 Vaginal Radical Trachelectomy in the Treatment of Cervical Cancer of Uterus : The Role of Frozen Section (966) C Tanguay, M Plante, MC Renaud, M Roy, B Tetu Hotel-Dieu de Quebec, Quebec City, Canada 135 Decreased Gelsolin Expression in Endometrial Carcinoma (967) HC Tsai, S Natarajan, R Jian-yu UCLA, Los Angeles, CA 136 Syndecan-1 (CD138) Expression in Adenocarcinomas of the Endometrium (976) C Willis, S Olson, K Washington, H Shappell Vanderbilt University Medical Center, Nashville, TN 137 Expression of Maspin and p53 in the Histologic Subtypes of Endometrial Carcinoma and in Uterine Mixed Mesodermal Tumors (977) JJ Xiong, CE Sheehan, H Xu, RA Ambros, JS Ross Albany Medical College, Albany, NY 138 Maspin Expression in In-Situ, Micro-Invasive and Invasive Squamous Cell Carcinomas of Uterine Cervix Suggests Its Possible Role in Disease Progression and Metastasis (979) C Xu, MR Quddus, CJ Sung, MM Steinhoff, C Zhang, TM Zheng, WD Lawrence Women & Infants Hospital; Brown Medical School, Providence, RI 139 Minimal Uterine Serous Carcinoma with Extrauterine Tumor of Identical Morphology: A Study of 13 Cases (983) Z Yan, V Parkash, W Zheng, P Schwartz, J Costa, P Hui Yale University School of Medicine, New Haven, CT 140 Cost-Effective Method for Histologic Processing of Uterine Prolapse Cases (984) H Yin, K Mittal Bellevue Hospital Center, New York, NY